29
/ru/
ru
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Создать
Public Timelines
Библиотека
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Скачать
Export
Создать копию
Встроить в сайт
Редактировать
Просмотров 308
0
0
New timeline
Apixaban clinical trial timeline
Создана
Sai Iyer Ph.D
⟶ Обновлено 4 окт 2017 ⟶
List of edits
Комментарии
Периоды
PHASE 3 OL - Apixaban vs. LMWH in clot reduction in CR-VTE
PHASE 1 - Single Dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic Disorder
Phase 2 PK/safety vs. VKA and LMWH in pts w/ congenital or acquired heart disease
Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE
PH 3 - Clot reduction in leukemia pediatrics with central catheters
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
VTE prevention in multiple myeloma